Steering Committee

The BBCIC Steering Committee manages the consortium’s charter, operational policies and procedures, and research plans. The Steering Committee oversees public communications for BBCIC activities and findings. 

BBCIC Steering Committee Members

• Chairperson: Mark Cziraky, PharmD, Vice President, Elevance Health, and President, Carelon Research
• Rebekah Angove, Vice President Patient Experience and Evaluation, Patient Advocate Foundation
• Leah Christl, PhD, Executive Director, Global Regulatory and R&D Policy, JAPAC Lead and Global Biosimilars, Amgen
• Jeffrey R. Curtis, Marguerite Jones Harbert – Gene Ball Endowed Professor of Medicine, University of Alabama, Division of Clinical Immunology & Rheumatology
• Audrey Djibo, PhD, Epidemiologist, Lead Data Scientist, CVS Health
• Amy Gross, PharmD, BCPP, Director, Clinical Specialists, Express Scripts Inc
• Katherine Harris, Principal Scientist, Carelon Research
• Michael Hasenkamp, Director of Sales, PearlDiver Technologies™
• Anna Hyde, Vice President of Advocacy and Access| Department of Advocacy and Access, Arthritis Foundation
• James T. Kenney, MBA, RPh, Founder and President, JTKENNEY, LLC
• Ed Li, PharmD, MPH, Head, HEOR and Oncology, Sandoz
• Cheryl N. McMahill-Walraven, MSW, PhD, President & CEO, Glade Oak, Inc. 
• Josh Roth, PhD, MHA, Director, HTA, Value & Evidence, Biosimilars, Pfizer Inc.
• BBCIC Staff:
  • Cate Lockhart, PharmD, PhD, Executive Director, BBCIC

  • Pam Pawloski, PharmD, BCOP, FCCP, Pincipal Research Scientist, BBCIC

  • Julia Marsh, Director, Projects & Operations, BBCIC

  • Aaron B. Mendelsohn, PhD, MPH, Research Consultant, BBCIC
• BBCIC Counsel: George Constantine, JD, Counsel, BBCIC